Results 21 to 30 of about 60,497 (244)

The relationship of immunologic testing and candidiasis to end-stage renal disease: A review article

open access: yesمجلة مركز بحوث التقنيات الاحيائية
Background: This study investigates the relationship between immunological testing, candidiasis, and end-stage kidney disease (ESKD). Individuals with a compromised immune system, such as those with ESKD, are more vulnerable to the fungal infection ...
Sundus S. Mahdi, Thamer A. A. Muhsen
doaj   +1 more source

An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study

open access: yesBMC Oral Health, 2021
Background Oral candidiasis is a common problem associated with head and neck radiation therapy (RT) consequences being pain, burning sensation, taste change, and systemic infection.
Imjai Chitapanarux   +6 more
doaj   +1 more source

Congenital Candidiasis

open access: yesPediatrics & Neonatology, 2008
Congenital candidiasis presents with a variety of clinical features. We report two neonates with congenital candidiasis characterized by diffuse erythematous papules associated with pneumonia and respiratory distress. Candida pseudohyphae were identifiable in skin scrapings.
Shwu-Meei Wang   +2 more
openaire   +3 more sources

Use of Clotrimazole in Finfish Aquaculture: Mechanistic Insights, Limitations, and Future Directions for Antifungal Therapy

open access: yesAnimal Research and One Health, EarlyView.
This review critically evaluates clotrimazole as a potential antifungal for finfish aquaculture, highlighting strong mechanistic and in vitro efficacy against aquatic mycoses alongside major gaps in in vivo evidence, toxicokinetics, residue safety, and environmental risk, outlining priorities for responsible therapeutic development and regulatory ...
Arya Sen   +2 more
wiley   +1 more source

A Causal Relationship between Type 2 Diabetes and Candidiasis through Two-Sample Mendelian Randomization Analysis

open access: yesMicroorganisms
The potential relationship between type 2 diabetes (T2D) and candidiasis is of concern due to the respective characteristics of these conditions, yet the exact causal link between the two remains uncertain and requires further investigation.
Juan Xiong, Hui Lu, Yuanying Jiang
doaj   +1 more source

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher   +12 more
wiley   +1 more source

New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

open access: yesFrontiers in Microbiology, 2012
The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes orapharyngeal, esophageal, gastrointestinal, and vaginal infections.
Anna eVecchiarelli   +3 more
doaj   +1 more source

A preliminary study of suppression of candida infection by miconazole mucoadhesive tablets in oral or oropharyngeal cancer patients undergoing radiotherapy

open access: yesScientific Reports, 2022
Elevated numbers of candida in the oral cavity often lead to oral candidiasis development in patients undergoing radiotherapy for oral or oropharyngeal cancer.
Sakiko Soutome   +8 more
doaj   +1 more source

Hepatosplenic candidiasis [PDF]

open access: yesClinical Liver Disease, 2015
Watch a video presentation of this article Watch the interview with the author Answer questions and earn CME
Oliver A, Cornely   +2 more
openaire   +2 more sources

Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients 2–17 years with active pcJIA and inadequate response ...
Hermine I Brunner   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy